{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:24:38Z","timestamp":1787009078582,"version":"build-2736575974"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Toxic epidermal necrolysis (TEN) is a drug-mediated disease process that mimics a partial-thickness thermal injury. It has long been treated with frequent wound dressing changes and supportive care. There has been minimal efficacious systemic therapy. The pathophysiology is poorly understood but causes necrosis of keratinocytes at the dermal\u2013epidermal junction leading to sloughing of the epidermis. The disease is rare with high mortality rates associated with long hospital stays. This case report describes the application of autologous skin cell suspension to a patient with TEN after antihypertensive and hyperglycemic therapy. This was associated with minimal wound care and efficacious arrest of patient disease process and timely closure of wound.<\/jats:p>","DOI":"10.1093\/jbcr\/irab243","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T11:09:13Z","timestamp":1639393753000},"page":"508-513","source":"Crossref","is-referenced-by-count":2,"title":["Autologous Skin Cell Suspension Application for Toxic Epidermal Necrolysis: A Case Report"],"prefix":"10.1093","volume":"43","author":[{"given":"Alan","family":"Pang","sequence":"first","affiliation":[{"name":"Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theophilus","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Felan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Raghuram","sequence":"additional","affiliation":[{"name":"School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Brown","sequence":"additional","affiliation":[{"name":"School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bharadia","sequence":"additional","affiliation":[{"name":"Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Griswold","sequence":"additional","affiliation":[{"name":"Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"2022032516105933900_CIT0001","article-title":"Benedetti, J. (2021, December 16). Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) - skin disorders. Merck Manuals Consumer Version"},{"key":"2022032516105933900_CIT0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2015.06.033","article-title":"Skin biopsy: biopsy issues in specific diseases","volume":"74","author":"Elston","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2022032516105933900_CIT0003","doi-asserted-by":"crossref","first-page":"E2135","DOI":"10.3390\/ijms17122135","article-title":"Review of toxic epidermal necrolysis","volume":"17","author":"Harris","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2022032516105933900_CIT0004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","article-title":"A 10-year experience with toxic epidermal necrolysis","volume":"21","author":"Schulz","year":"2000","journal-title":"J Burn Care Rehabil"},{"key":"2022032516105933900_CIT0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.burns.2016.07.026","article-title":"Steven Johnson syndrome and toxic epidermal necrolysis in a burn unit: a 15-year experience","volume":"43","author":"McCullough","year":"2017","journal-title":"Burns"},{"key":"2022032516105933900_CIT0006","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.burns.2017.09.015","article-title":"Improving mortality outcomes of Stevens Johnson syndrome\/toxic epidermal necrolysis: a regional burns centre experience","volume":"44","author":"Nizamoglu","year":"2018","journal-title":"Burns"},{"key":"2022032516105933900_CIT0007","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0305-4179(95)00140-9","article-title":"Toxic epidermal necrolysis in a burns centre: a 6-year review","volume":"22","author":"Khoo","year":"1996","journal-title":"Burns"},{"key":"2022032516105933900_CIT0008","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.burns.2011.03.001","article-title":"Characterisation of the cell suspension harvested from the dermal epidermal junction using a ReCell\u00ae kit","volume":"38","author":"Wood","year":"2012","journal-title":"Burns"},{"key":"2022032516105933900_CIT0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098611404094","article-title":"Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality","volume":"2","author":"Roujeau","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"2022032516105933900_CIT0010","article-title":"Exsurco. Training Tool to Optimize Performance of the Amalgatome MD. Wakeman, Ohio: Exsurco; 2018."},{"key":"2022032516105933900_CIT0011","doi-asserted-by":"crossref","first-page":"187.e1","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Burn Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbcr\/advance-article-pdf\/doi\/10.1093\/jbcr\/irab243\/41922751\/irab243.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbcr\/article-pdf\/43\/2\/508\/42981571\/irab243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbcr\/article-pdf\/43\/2\/508\/42981571\/irab243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T16:55:14Z","timestamp":1648227314000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbcr\/article\/43\/2\/508\/6460470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,13]]},"published-print":{"date-parts":[[2022,3,23]]}},"URL":"https:\/\/doi.org\/10.1093\/jbcr\/irab243","relation":{},"ISSN":["1559-047X","1559-0488"],"issn-type":[{"value":"1559-047X","type":"print"},{"value":"1559-0488","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,12,13]]}}}